Abstract
Purpose
To discuss the evaluation of the enhancement curve over time of the major renal cell carcinoma (RCC) subtypes, oncocytoma, and lipid-poor angiomyolipoma, to aid in the preoperative differentiation of these entities. Differentiation of these lesions is important, given the different prognoses of the subtypes, as well as the desire to avoid resecting benign lesions.
Methods
We discuss findings from CT, MR, and US, but with a special emphasis on contrast-enhanced ultrasound (CEUS). CEUS technique is described, as well as time–intensity curve analysis.
Results
Examples of each of the major RCC subtypes (clear cell, papillary, and chromophobe) are shown, as well as examples of oncocytoma and lipid-poor angiomyolipoma. For each lesion, the time–intensity curve of enhancement on CEUS is reviewed, and correlated with the enhancement curve over time reported for multiphase CT and MR.
Conclusions
Preoperative differentiation of the most common solid renal masses is important, and the time–intensity curves of these lesions show some distinguishing features that can aid in this differentiation. The use of CEUS is increasing, and as a modality it is especially well suited to the evaluation of the time–intensity curve.
Similar content being viewed by others
References
American Cancer Society (2014) Cancer facts and figures 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed 20 Aug 2014
Kutikov A, Fossett LK, Ramchandani P, et al. (2006) Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology 68(4):737–740
Remzi M, Ozsoy M, Klingler HC, et al. (2006) Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176(3):896–899
Fujii Y, Komai Y, Saito K, et al. (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72(3):598–602
Jeon HG, Lee SR, Kim KH, et al. (2010) Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients. Urology 76(3):574–579
Sasiwimonphan K, Takahashi N, Leibovich BC, et al. (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology 263(1):160–168
Hindman N, Ngo L, Genega EM, et al. (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265(2):468–477
Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26(6):1795–1806
Crumley SM, Divatia M, Truong L, et al. (2013) Renal cell carcinoma: Evolving and emerging subtypes. World J Clin Cases 1(9):262–275
Shuch B, Amin A, Armstrong AJ, et al. (2015) Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol 67(1):85–97
Ng CS, Wood CG, Silverman PM, et al. (2008) Renal cell carcinoma: diagnosis, staging, and surveillance. Am J Roentgenol 191(4):1220–1232
Gerst S, Hann LE, Li D, et al. (2011) Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. Am J Roentgenol 197(4):897–906
Jinzaki M, Tanimoto A, Mukai M, et al. (2000) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 24(6):835–842
MacLennan GT, Bostwick DG (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46(1):27–30
Piscaglia F, Nolsøe C, Dietrich CF, et al. (2011) The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. https://www.thieme-connect.de/DOI/DOI?10.1055/s-0031-1281676. Accessed 8 Aug 2014
Lantheus Medical Imaging. Definity prescribing information. http://www.definityimaging.com/pdf/DEFINITY%20Prescribing%20Information%20515987-0413.pdf. Accessed 9 Aug 2014
Correas JM, Bridal L, Lesavre A, et al. (2001) Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 11(8):1316–1328
McArthur C, Baxter GM (2012) Current and potential renal applications of contrast-enhanced ultrasound. Clin Radiol 67(9):909–922
Wei K, Mulvagh SL, Carson L, et al. (2008) The safety of definity and optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 21(11):1202–1206
Main ML, Goldman JH, Grayburn PA (2007) Thinking outside the “box”—the ultrasound contrast controversy. J Am Coll Cardiol 50(25):2434–2437
Main ML, Hibberd MG, Ryan A, et al. (2014) Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovasc Imaging 7(1):40–48
Xue LY, Lu Q, Huang BJ, et al. (2014) Contrast-enhanced ultrasonography for evaluation of cystic renal mass: in comparison to contrast-enhanced CT and conventional ultrasound. Abdom Imaging 39(6):1274–1283
Aoki S, Hattori R, Yamamoto T, et al. (2011) Contrast-enhanced ultrasound using a time–intensity curve for the diagnosis of renal cell carcinoma. BJU Int 108(3):349–354
Cai Y, Du L, Li F, Gu J, Bai M (2014) Quantification of enhancement of renal parenchymal masses with contrast-enhanced ultrasound. Ultrasound Med Biol 40(7):1387–1393
Young JR, Margolis D, Sauk S, et al. (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267(2):444–453
Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27(5):612–624
Olshan AF, Kuo TM, Meyer AM, et al. (2013) Racial difference in histologic subtype of renal cell carcinoma. Cancer Med 2(5):744–749
Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490
Hagenkord JM, Gatalica Z, Jonasch E, Monzon FA (2011) Clinical genomics of renal epithelial tumors. Cancer Genet 204(6):285–297
Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33(5):534–543
Polascik TJ, Bostwick DG, Cairns P (2002) Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60(6):941–946
Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA (2005) Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 174(2):451–455
Kim JK, Kim TK, Ahn HJ, et al. (2002) Differentiation of subtypes of renal cell carcinoma on helical CT scans. Am J Roentgenol 178(6):1499–1506
Sun MR, Ngo L, Genega EM, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802
Fan L, Lianfang D, Jinfang X, Yijin S, Ying W (2008) Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med 27(6):875–885
Xu ZF, Xu HX, Xie XY, et al. (2010) Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 29(5):709–717
Lu Q, Xue L, Huang B, et al. (2014) Histotype differentiation of hypo-echoic renal tumors on CEUS: usefulness of enhancement homogeneity and intensity. Abdom Imaging. doi:10.1007/s00261-014-0340-5
Lu Q, Li CX, Huang BJ, Xue LY, Wang WP (2015) Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features. Abdom Imaging 40(2):333–342
Vikram R, Ng CS, Tamboli P, et al. (2009) Papillary renal cell carcinoma: radiologic–pathologic correlation and spectrum of disease. Radiographics 29(3):741–754
Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G (2004) Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. Am J Roentgenol 183(5):1387–1391
Herts BR, Coll DM, Novick AC, et al. (2002) Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. Am J Roentgenol 178(2):367–372
Zhang J, Lefkowitz RA, Ishill NM, et al. (2007) Solid renal cortical tumors: differentiation with CT. Radiology 244(2):494–504
Scialpi M, Di Maggio A, Midiri M, et al. (2000) Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. Am J Roentgenol 175(3):751–757
Vera-Badillo FE, Conde E, Duran I (2012) Chromophobe renal cell carcinoma: a review of an uncommon entity. Int J Urol 19(10):894–900
Kim JI, Cho JY, Moon KC, Lee HJ, Kim SH (2009) Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. Radiology 252(2):441–448
Rosenkrantz AB, Hindman N, Fitzgerald EF, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. Am J Roentgenol 195(6):W421–W427
O’Malley ME, Tran P, Hanbidge A, Rogalla P (2012) Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT? Am J Roentgenol 199(6):1312–1315
Woo S, Cho JY, Kim SH, et al. (2013) Segmental enhancement inversion of small renal oncocytoma: differences in prevalence according to tumor size. Am J Roentgenol 200(5):1054–1059
Schieda N, Al-Subhi M, Flood TA, El-Khodary M, McInnes MD (2014) Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI). Eur Radiol 24(11):2787–2794
Gakis G, Kramer U, Schilling D, et al. (2011) Small renal oncocytomas: differentiation with multiphase CT. Eur J Radiol 80(2):274–278
Tamai H, Takiguchi Y, Oka M, et al. (2005) Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 24(12):1635–1640
Wu Y, Du L, Li F, et al. (2013) Renal oncocytoma: contrast-enhanced sonographic features. J Ultrasound Med 32(3):441–448
Halpenny D, Snow A, McNeill G, Torreggiani WC (2010) The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol 65(2):99–108
Froemming AT, Boland J, Cheville J, Takahashi N, Kawashima A (2013) Renal epithelioid angiomyolipoma: imaging characteristics in nine cases with radiologic-pathologic correlation and review of the literature. Am J Roentgenol 200(2):W178–W186
Jinzaki M, Silverman SG, Akita H, et al. (2014) Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging 39(3):588–604
Chaudhry HS, Davenport MS, Nieman CM, Ho LM, Neville AM (2012) Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma. Am J Roentgenol 198(2):377–383
Kim JK, Park SY, Shon JH, Cho KS (2004) Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 230(3):677–684
Yang CW, Shen SH, Chang YH, et al. (2013) Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? Am J Roentgenol 201(5):1017–1028
Acknowledgments
This work was supported by a seed grant from the Radiological Society of North America, and a grant from GE Healthcare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
King, K.G., Gulati, M., Malhi, H. et al. Quantitative assessment of solid renal masses by contrast-enhanced ultrasound with time–intensity curves: how we do it. Abdom Imaging 40, 2461–2471 (2015). https://doi.org/10.1007/s00261-015-0468-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-015-0468-y